SS
DMAA

Steve Schonfeld’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

Steve Schonfeld’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-149,215
Closed -$1.52M – 2673
2025
Q2 		$1.52M Sell
149,215
-50,785
-25% -$514K 0.01% 1119
2025
Q1 		$2M Buy
+200,000
New +$2M 0.01% 967

Other funds holding DMAA

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Steve Schonfeld's DMAA Position: Q3 2025 in Review

Steve Schonfeld sold out of Drugs Made In America Acquisition Corp (DMAA) in Q3 2025, closing a stake of 149,215 shares — an estimated $1.52M sold.

Steve Schonfeld first reported a position in DMAA in Q1 2025 and held it in 2 quarters. The position peaked at $2M in Q1 2025. 37 funds tracked by Wall St. Rank hold DMAA as of Q3 2025.

  • Steve Schonfeld reported no remaining Drugs Made In America Acquisition Corp position as of Q3 2025 after selling out during the quarter.
  • Steve Schonfeld sold 149,215 Drugs Made In America Acquisition Corp shares in Q3 2025, an estimated $1.52M.
  • Steve Schonfeld first reported a position in Drugs Made In America Acquisition Corp in Q1 2025 and held it in 2 quarters.
  • Steve Schonfeld's Drugs Made In America Acquisition Corp position peaked at $2M in Q1 2025.
  • 37 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.